14th Apr 2025 10:08
(Alliance News) - The following stocks are the leading risers and fallers on AIM on Monday.
----------
AIM - WINNERS
----------
Distil PLC, up 25% at 0.0875 pence, 12-month range 0.045p-0.6p. The London-based owner of premium alcoholic drinks brands such as RedLeg Spiced Rum, Blackwoods Gin and Gem Diva announces a new partnership with US distributor Aiko Importers Inc "to bring Blavod Black Vodka back into the US market". Says the deal "marks a significant step in the North American relaunch of Blavod", giving the brand "immediate national reach" through Aiko's network of 185 distribution partners and "strong retail relationships" with companies like Costco Wholesale Corp.
----------
Scancell Holdings PLC, up 21% at 10 pence, 12-month range 7.5p-19.5p. The Oxford, UK-based pharmaceutical firm announces a partnership with the NHS Cancer Vaccine Launch Pad, which it says will fast-track access for NHS patients into the fourth cohort of its phase 2 Scope clinical trial. Says this cohort will evaluate intradermal administration of Scancell's iSCIB1+ targeted 'off-the-shelf' Immunobody second-generation DNA cancer vaccine, in patients with advanced unresectable melanoma receiving standard of care immunotherapy treatments. "NHS Hospitals across the country will be able to take part in this transformational study, with eligible patients from around the UK being referred to a participating NHS site," Scancell says. Expects the first patients to be referred from May onwards. Chief Medical Officer Nermeen Varawalla comments: "Recent clinical data has demonstrated that our potent, tumour-targeted 'off-the-shelf' cancer vaccine delivers strong efficacy, with the potential for meaningful long-term survival benefits in patients with advanced metastatic melanoma. Our partnership with the CVLP will give patients expedited access to this landmark study and is an important step in accelerating the clinical development of this important new treatment."
----------
AIM - LOSERS
----------
Pantheon Resources PLC, down 44% at 29.325p, 12-month range 15p-70.7p. The Alaska-focused oil and gas explorer reports preliminary results from the flow testing of the Topset 1 or TS1 reservoir interval, the first of six intervals in the planned Megrez-1 well testing programme. Says no appreciable hydrocarbons were produced from the well, adding: "Preliminary analysis indicates that although the reservoir is oil bearing, it appears to be in a transition zone with limited to no mobile oil and gas." Says however that the data increases its confidence in the productivity and hydrocarbon potential of the intervals higher in the wellbore, and indicates that mobile oil will be found in the shallower stratigraphic sequences. Intends to abandon TS1 and commence well operations to test the Lower Prince Creek interval "as soon as high-pressure pumping equipment is mobilised to the Megrez pad". Chief Executive Officer Max Easley comments: "Whilst at face value it appears disappointing that the first and deepest interval did not produce material hydrocarbons, when you take a closer look, the data we gathered leaves us with increased confidence in the five shallower and more productive horizons that remain to be tested. We are confident that these further five zones will, in aggregate, add high-quality inventory to our already significant 1.6 billion barrels of certified resources in Ahpun and Kodiak."
----------
By Emma Curzon, Alliance News reporter
Comments and questions to [email protected]
Copyright 2025 Alliance News Ltd. All Rights Reserved.
Related Shares:
DistilScancell HoldingsPantheon Resources plc